Andrea Imperatori, MD

Department of Surgical and Morphological Sciences, School of Medicine, University of Insubria, Varese, Italy

Andrea Imperatori is an Associate Professor of Thoracic Surgery at the Department of Surgical and Morphological Sciences, University of Insubria, Varese (see website:

He received his MD Degree in Medicine and Surgery at the University of Pavia in 1994, and his postgraduate in Surgery at the Insubria University in 2000. He was Visiting Research Fellow at the University Hospital of North Tees, Stockton on Tees, United Kingdom (2000). He was Clinical Observer at the Department of Interdisciplinary Endoscopy Thoraxklinik, Heidelberg University (2005), and at the Department of Thoracic Surgery of the Osaka Medical Center for Cancer and Cardiovascular Diseases (2008).

He is Consultant at the Center for Thoracic Surgery of the University Hospital of Varese, Italy. Since 2011 he has been Director of Postgraduate School of Thoracic Surgery School of Medicine, University of Insubria, Varese, Italy.

He is a member of the Editorial Board of the Journal of Thoracic Disease and Associate Editor of the World Journal of Respirology. He organized as Scientific Secretary or co-organizer of 33 National or International scientific meetings on lung cancer, mini-invasive surgical techniques, surgical infections.

He is author or co-author of 154 scientific papers on lung cancer, pleural mesothelioma, thoracic surgery, surgical infections, oncological surgery. The 62 publications included in Scopus (Elsevier) have 670 citations and an h-index=16, updated on October 31, 2016.

He is an active member of International Association for the Study of Lung Cancer (IASLC), European Society of Thoracic Surgery (ESTS), of Italian Society of Thoracic Surgery (SICT) as Councillor, and of Italian VATS Group as Councillor. 

His main clinical interests focus on:
Minimally invasive thoracic surgery
VATS lobectomy
Thoracic oncology
Medical devices

His research interests and main publications focus on:
Lung cancer screening
Lung cancer prognostic factors (molecular markers, genetic and epigenetic factors, natural killer cells)
Peri-operative risk assessment
Surgical infections